Project Grant HT94252510316
Award Date
5/1/25
Completion Date
4/30/27
Dollars Obligated
$957K
Federal Agency
Defense Health Agency
Awardee
Brown University (E3FDXZ6TBHW3)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Providence, RI 02912, USA
Similar Awards
The Department of the Army Medical Command awarded Yale University a $738,509 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into "THE ROLE OF TLR7/8-ACTIVATING MICRORNAS IN OBSTETRIC ANTIPHOSPHOLIPID SYNDROME" from September 30, 2021 to September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and...
The Department of the Army Medical Command, through the Military Medical Research and Development federal grant program (CFDA 12.420), awarded a $628,292 project grant to the Boston VA Research Institute, Inc. The funding supports advanced biomedical research focused on investigating military-related toxic exposures as a risk factor for amyotrophic lateral sclerosis (ALS). The 3-year project grant, active from July 1, 2024 to June 30, 2027, will be conducted by the non-profit Boston VA...
The University of Massachusetts Medical School was awarded a $749,992 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2025 to study the role of SCARF1 in efferocytosis and the prevention of lupus. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
The Department of the Army Medical Command awarded a $1,180,437 Project Grant to the University of California, Los Angeles (UCLA) under the Military Medical Research and Development program (CFDA 12.420). The grant supports UCLA's research to evaluate circulating cell-free DNA as a biomarker for diagnosing and tracking the progression of amyotrophic lateral sclerosis (ALS). The award began on March 1, 2024 and is scheduled for completion by February 28, 2026. Through this Project Grant, UCLA...
This $859,773 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports research by Yale University on biomarkers and targets of leptomeningeal disease progression from non-small cell lung cancer (NSCLC) brain metastasis. The award period runs from May 1, 2025 to April 30, 2028. The research aims to transform healthcare for military service members and the broader public by investigating...
The Department of the Army Medical Command, under the Military Medical Research and Development (CFDA 12.420) federal grant program, awarded a $201,000 Project Grant to Yale University on March 1, 2025. The grant supports advanced biomedical research focused on investigating the role of the RBM10 gene in the histologic transformation to lung squamous cell carcinoma. This research aims to transform healthcare for military service members and the broader public by advancing the scientific...
The University of Massachusetts Medical School has been awarded a $987,615 federal Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from September 30, 2024 to September 29, 2026, supports the "Development of Chimeric Antigen Receptor T Regulatory Cells (CAR Tregs) for the Treatment of Amyotrophic Lateral Sclerosis." This project aims to advance research into new therapeutic approaches for...
The Department of the Army Medical Command awarded a $400,000 Project Grant to Augusta University Research Institute, Inc. for research under the Military Medical Research and Development program. The grant will fund research from July 1, 2022 to May 30, 2024 to identify mechanisms and treatments for cognitive decline following neurotoxic alpha-synuclein exposure in new Parkinson's disease models. The Military Medical Research and Development program supports biomedical research with the goals...
The U.S. Department of the Army Medical Command awarded The Leland Stanford Junior University (Stanford University) a $1,045,651 Project Grant on September 30, 2024 under the Military Medical Research and Development program (CFDA 12.420). The funding will support research to develop novel statistical methods for integrating high-dimensional clinical markers to evaluate treatment efficacy in amyotrophic lateral sclerosis (ALS) clinical trials. This research aims to transform health care for...
The University of Massachusetts Medical School was awarded a $1,005,000 Project Grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to develop pad inhibitors for the treatment of amyotrophic lateral sclerosis (ALS). The award, which commenced on September 30, 2024, will support research activities through September 29, 2026. The Medical School's Grants and Contracts Administration division, doing business as UMms, will lead the project...